Berres Jennifer

HCA SVP/Chief HR Officer Berres sells 8,020 shares across 2 transactions for $4,126,950.05

Jennifer Berres, SVP and Chief Human Resources Officer, executed 2 separate sales totaling 8,020 shares for $4,126,950.05 on 2026-02-11, at blended average price of $514.58. This represents a -40.1% reduction in her HCA holdings, bringing her remaining stake to 11,993 shares. The timing of the sales coincides with HCA trading near its 52-week high ($535.22 current price, +0.0% from 52-week high), and follows the stock's strong 30-day (+11.7%) and 90-day (+13.2%) appreciation. Her prior sales at HCA (2 trades on 2025-02-14) yielded positive 90-day returns (+19.4% and +19.6%), indicating the stock has historically moved higher after her sells at this ticker. The company's fundamentals remain solid with $19.2B in quarterly revenue, $1.6B net income, and +7.1% annual revenue growth.

HCA Healthcare SVP & Chief HR Officer Jennifer Berres sold 9,533 shares (38.2% of holdings) for $3,075,240.24 on 2025-02-14

Berres executed 2 separate sales on 2025-02-14 totaling 9,533 shares for $3,075,240.24 at a blended average price of $322.59, reducing her post-transaction holdings to 15,412 shares from 24,945 shares. The transaction occurred when HCA's stock trades at $316.71, only 1.8% below her execution prices and near its 30-day high (+2.0%), suggesting the sale was not executed during a depressed window. At 12.20 P/E and $17.5B in quarterly revenue with +8.7% annual growth, HCA remains a financially stable large-cap health care operator; the sale represents a meaningful reduction in this insider's concentrated position rather than a signal about the underlying business.